BLOOD CYTOKINE RESPONSE OF LOW-DOSE MOLGRAMOSTIM (rhGM-CSF)-TREATED PATIENTS
Open Access
- 31 October 2000
- Vol. 12 (10), 1570-1574
- https://doi.org/10.1006/cyto.2000.0752
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopeniaEuropean Journal of Haematology, 2009
- Immunomodulation by colony-stimulating factorsReviews of physiology, biochemistry and pharmacology, 1999
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivoAnnals of Hematology, 1996
- Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions.Journal of Clinical Investigation, 1996
- Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.Journal of Clinical Investigation, 1994
- Effects of continuous high dose rhgm‐csf infusion on human monocyte activityAmerican Journal of Hematology, 1993